Show simple item record

dc.contributor.authorHimanshu, Men
dc.contributor.authorSingh, Karam Romeoen
dc.contributor.authorShougrakpam, Jeeteshen
dc.date.accessioned2018-07-27T11:03:39Z
dc.date.available2018-07-27T11:03:39Z
dc.date.issued2018-07
dc.identifier.urihttp://hdl.handle.net/10144/619217
dc.descriptionResearch Protocolen
dc.description.abstract4. OBJECTIVES Primary objective The primary objective of this study is to assess the effectiveness of HCV curative treatments in patients with chronic hepatitis C (CHC), co-infected with HIV in Manipur, India. Secondary objectives a. To describe the demographic, clinical and biological characteristics of patients with chronic hepatitis C and HIV co-infection b. To assess the effectiveness of HCV curative strategies in patients with chronic HCV, co-infected with HIV stratified by regimen and by site c. To identify risk factors associated with differing virological responses d. To assess the safety of HCV treatment e. To monitor the safety of HCV treatment in HIV co-infected patients f. To document the clinical and biological tolerance of the HCV treatment g. To assess the feasibility of HCV treatment h. To assess comparative performance of elastography (Fibroscan®) and APRI (AST to Platelet Ration Index), to evaluate liver fibrosis among HIV/HCV co-infected individuals i. To describe causes of non-eligibility for treatment j. To describe the clinical and biological evolution of co-infected patients, not eligible for HCV treatment k. To assess treatment adherence
dc.language.isoenen
dc.rightsThese materials can be used, adapted and copied as long as citation of the source is given including the direct URL to the material. This work is licensed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0/ https://i.creativecommons.org/l/by/4.0/88x31.pngen
dc.subjectHepatitis Cen
dc.subjectHIVen
dc.subjectManipuren
dc.subjectIndiaen
dc.titleLongitudinal cohort to evaluate Hepatitis C treatment effectiveness in HIV co-infected patients: Manipur, Indiaen
dc.typeOtheren
dc.contributor.departmentMSF-OCAen
refterms.dateFOA2019-03-04T14:03:53Z
html.description.abstract4. OBJECTIVES Primary objective The primary objective of this study is to assess the effectiveness of HCV curative treatments in patients with chronic hepatitis C (CHC), co-infected with HIV in Manipur, India. Secondary objectives a. To describe the demographic, clinical and biological characteristics of patients with chronic hepatitis C and HIV co-infection b. To assess the effectiveness of HCV curative strategies in patients with chronic HCV, co-infected with HIV stratified by regimen and by site c. To identify risk factors associated with differing virological responses d. To assess the safety of HCV treatment e. To monitor the safety of HCV treatment in HIV co-infected patients f. To document the clinical and biological tolerance of the HCV treatment g. To assess the feasibility of HCV treatment h. To assess comparative performance of elastography (Fibroscan®) and APRI (AST to Platelet Ration Index), to evaluate liver fibrosis among HIV/HCV co-infected individuals i. To describe causes of non-eligibility for treatment j. To describe the clinical and biological evolution of co-infected patients, not eligible for HCV treatment k. To assess treatment adherence


Files in this item

Thumbnail
Name:
Protocol_Proposed_MSF_Observat ...
Size:
2.238Mb
Format:
PDF
Description:
Research Protocol

This item appears in the following Collection(s)

Show simple item record